Related Experiment Video
Updated: Dec 24, 2025

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Published on: February 24, 2023
Targeting DNA Repair in Ovarian Cancer Treatment Resistance
M W Wong-Brown1, A van der Westhuizen2, N A Bowden3
1School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, NSW, Australia; Centre for Drug Repurposing and Medicines Research, University of Newcastle, NSW, Australia; Hunter Medical Research Institute, Newcastle, NSW, Australia.
High-grade serous ovarian cancer often recurs due to chemotherapy resistance. DNA repair pathway redundancies and epigenetic changes can cause resistance, but new therapies may restore platinum sensitivity.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- High-grade serous ovarian cancer (HGSOC) frequently recurs within 3 years and is fatal within 5 years.
- Standard treatment involves surgery and platinum/taxol chemotherapy, but resistance develops.
- Chemotherapy resistance is a major challenge in HGSOC treatment and recurrence.
Purpose of the Study:
- To investigate the role of DNA repair pathway redundancies in platinum chemotherapy resistance in HGSOC.
- To explore how epigenetic alterations, such as DNA methylation, contribute to chemoresistance.
- To identify potential therapeutic strategies to overcome chemotherapy resistance in HGSOC.
Main Methods:
- Analysis of DNA repair pathways involved in response to DNA damage from platinum chemotherapy.
- Investigation of epigenetic modifications, specifically DNA methylation, in HGSOC cells.
- Review of existing and novel therapeutic approaches targeting DNA repair mechanisms.
Main Results:
- Redundant DNA repair pathways can compensate for deficiencies, leading to cancer cell survival and platinum resistance.
- Epigenetic inactivation of repair pathways via DNA methylation can prevent cell death and promote resistance.
- Targeting DNA repair pathways offers potential to re-sensitize resistant ovarian cancers to chemotherapy.
Conclusions:
- DNA repair pathway redundancy and epigenetic dysregulation are key mechanisms of platinum resistance in HGSOC.
- Therapeutic strategies aimed at modulating DNA repair can overcome treatment resistance.
- Further research into these mechanisms may lead to improved outcomes for ovarian cancer patients.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Overview of DNA Repair
Chemically...
Overview of DNA Repair

